Cochrane Abstracts
Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL): Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Role of Chemotherapy Additional to High-dose Methotrexate for Primary Central Nervous System Lymphoma (PCNSL): Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434779/all/Role_of_chemotherapy_additional_to_high_dose_methotrexate_for_primary_central_nervous_system_lymphoma__PCNSL_:_Cochrane_systematic_review.
Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL): Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434779/all/Role_of_chemotherapy_additional_to_high_dose_methotrexate_for_primary_central_nervous_system_lymphoma__PCNSL_:_Cochrane_systematic_review. Accessed December 8, 2024.
Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL): Cochrane systematic review. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434779/all/Role_of_chemotherapy_additional_to_high_dose_methotrexate_for_primary_central_nervous_system_lymphoma__PCNSL_:_Cochrane_systematic_review
Role of Chemotherapy Additional to High-dose Methotrexate for Primary Central Nervous System Lymphoma (PCNSL): Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434779/all/Role_of_chemotherapy_additional_to_high_dose_methotrexate_for_primary_central_nervous_system_lymphoma__PCNSL_:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL): Cochrane systematic review
ID - 434779
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434779/all/Role_of_chemotherapy_additional_to_high_dose_methotrexate_for_primary_central_nervous_system_lymphoma__PCNSL_:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
